Blog

The Director General of AFKMED, Lin Ving, today led a delegation to the National Agency for the Control of AIDS (NACA) headquarters to present the organization’s latest diagnostic innovations. The meeting with the Director General of NACA, Dr. Temitope Ilori, and the agency’s management team focused on the introduction of specialized HIV and Tuberculosis (TB) testing kits designed to enhance rapid diagnosis and treatment monitoring.
The presentation highlighted the technical specifications and reliability of the kits, emphasizing their potential to support Nigeria’s ongoing efforts in controlling these infectious diseases. By integrating advanced testing technology, the goal is to further decentralize screening and ensure more Nigerians have access to early and accurate results.
In her response, Dr. Temitope Ilori welcomed the technological advancements brought forward by the AFKMED team. She reaffirmed NACA’s dedication to enhancing strategic partnerships that align with national health goals. Dr. Temitope assured the delegation of the agency’s readiness for collaboration once the diagnostic kits have successfully undergone the necessary evaluations and are officially captured within the national testing algorithm